Author

Ann-Sofie M.E. Schauwvlieghe

Observed names: A. M. E. Schauwvlieghe, A.M.E. Schauwvlieghe, Ann-Sofie M. E. Schauwvlieghe, Ann-Sofie Schauwvlieghe

Institutions: Amsterdam University Medical Centers, University of Amsterdam

Observed institutions: Amsterdam UMC Location University of Amsterdam, Amsterdam University Medical Centers, University of Amsterdam

ORCID: 0000-0002-0020-4842

Observed ORCID: 0000-0002-0020-4842

OpenAlex ID: A5031015752

Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study

2016 · A. M. E. Schauwvlieghe, G. Dijkman, et al. · PLoS ONE · 88

Predictive Value of Optical Coherence Tomographic Features in the Bevacizumab and Ranibizumab in Patients With Diabetic Macular Edema (brdme) Study

2017 · Ward Fickweiler, Ann-Sofie M. E. Schauwvlieghe, et al. · Retina · 47

Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion

2020 · Maartje J.C. Vader, Ann-Sofie M.E. Schauwvlieghe, et al. · Ophthalmology Retina · 34

Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME)

2020 · Maartje J.C. Vader, Ann-Sofie M.E. Schauwvlieghe, et al. · Ophthalmology Retina · 22

Bilateral Serous Retinal Detachment and Uveitis Associated With Pembrolizumab Treatment in Metastatic Melanoma

2020 · Ewout W. de Vries, Ann-Sofie Schauwvlieghe, et al. · Retinal Cases & Brief Reports · 18

Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)

2015 · A.M.E. Schauwvlieghe, G. Dijkman, et al. · BMC Ophthalmology · 18

Antiplatelet and Anticoagulant Drugs Do Not Affect Visual Outcome in Neovascular Age-Related Macular Degeneration in the BRAMD Trial

2018 · Gabriëlle H.S. Buitendijk, Ann-Sofie M.E. Schauwvlieghe, et al. · American Journal of Ophthalmology · 17

Serious Adverse Events with Bevacizumab or Ranibizumab for Age-Related Macular Degeneration: Meta-analysis of Individual Patient Data

2017 · Maureen G. Maguire, James Shaffer, et al. · Ophthalmology Retina · 16

Comparing the effectiveness of bevacizumab to ranibizumab in patients with exudative age-related macular degeneration. BRAMD

2014 · Ann-Sofie M.E. Schauwvlieghe, Greetje Dijkman, et al. · Investigative Ophthalmology & Visual Science · 8

Comparing the efficacy of bevacizumab to ranibizumab in patients with diabetic macular edema: the BRDME study

2019 · Maartje J.C. Vader, Ann-Sofie M.E. Schauwvlieghe, et al. · Investigative Ophthalmology & Visual Science

Antiplatelet and anticoagulant drugs do not affect visual acuity in neovascular age-related macular degeneration. The BRAMD Study

2017 · Gabriëlle H.S. Buitendijk, Ann-Sofie M.E. Schauwvlieghe, et al. · Investigative Ophthalmology & Visual Science

Antiplatelet and anticoagulant drugs do not affect visual acuity in the comparing bevacizumab to ranibizumab in age-related macular degeneration (BRAMD) trial

2017 · Ann-Sofie M.E. Schauwvlieghe, Gabriëlle H.S. Buitendijk, et al. · Data Archiving and Networked Services (DANS)

Works count: 14

Citation count: 302

H-index: 10

I10-index: 10